Huake Holding Biology Co., Ltd (HUAK)
| Market Cap | 125.00M |
| Revenue (ttm) | 14.64M |
| Net Income (ttm) | 1.70M |
| Shares Out | 25.00M |
| EPS (ttm) | 0.07 |
| PE Ratio | 73.36 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About HUAK
Huake Holding Biology Co., is a Cayman Islands exempted company engaging in the production and sales camellia seed oil (“Camellia Oil”) products in China. We conduct our operations through a contractually controlled entity in the PRC named Anhui Aokai Fa Grease Technology Co., Ltd. (“Aokai Fa”), a large-scale producer of Camellia Oil, and we are now one of the leading enterprises of forestry and agricultural industrialization in the Anhui province. We integrate scientific research, farming, production, and sales. Aokai Fa guarantees the...
Financial Performance
In 2020, HUAK's revenue was $14.64 million, an increase of 5.07% compared to the previous year's $13.93 million. Earnings were $1.70 million, an increase of 5.78%.
Financial StatementsNews
Huake Holding Biology IPO Registration Document (S-1)
Huake Holding Biology Co., Ltd has filed to go public with an IPO on the NASDAQ.